Here are relevant reports on : baby-musical-instruments-market
-
Cell-free Protein Synthesis Market by Offering (Cell Extract Systems (Prokaryotic, Mammalian, Plant), Kits, Instruments, Services), Workflow, Method (Coupled TX/TL, Transcription, Translation), Application (Protein Purification) - Global Forecast to 2030
The global cell-free protein synthesis market, valued at US$203.9 million in 2024, stood at US$217.2 million in 2025 and is projected to advance at a resilient CAGR of 7.3% from 2024 to 2030, culminating in a forecasted valuation of US$308.9 million by the end of the period. Market growth is driven by increasing demand for biologics, vaccines, and personalized medicine, advancements in CFPS technologies, the need for quick prototyping of complex proteins, and the demand for commercial-scale validation of cell-free protein expression systems.
- Published: October 2025
- Price: $ 4950
- TOC Available:
-
DNA Diagnostics Market by Product (Instruments, Reagents & Kits, Services & Software), Technology (PCR, Mass Spectroscopy, Microarrays), Application (Infectious Disease (Hepatitis, HIV, HPV), Oncology), Specimen (Blood, Urine) - Global Forecast to 2029
The global DNA diagnostics market, valued at US$12.3 billion in 2023, stood at US$13.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.7% from 2024 to 2029, culminating in a forecasted valuation of US$21.2 billion by the end of the period. Growth in the market is primarily driven by the technological improvements in the DNA diagnostics industry and the growing need for personalized treatment and early disease diagnosis in developing nations. Also, the increased investments by healthcare-based companies are majorly contributing to growth of the market.
- Published: July 2024
- Price: $ 4950
- TOC Available:
-
Acoustic Emission Testing Market by Equipment (Sensors, Amplifiers, Detection Instruments), Service (Inspection, Calibration), Application (Storage Tank, Pipeline, Aging Aircraft, Structural Monitoring, Turbine), and Geography - Global Forecast to 2035
The acoustic emission testing market is expected to be valued at USD 349.9 million by 2023, from USD 226.6 million in 2017, at a CAGR of 7.32% between 2018 and 2023. The base year considered for the study is 2017, and the forecast period is between 2018 and 2023. The report profiles the most promising players in the market. The competitive landscape presents an interesting picture, where a large number of big and small players have become a force to reckon with. The key players in this market are TUV Rheinland (Germany), MISTRAS (US), TUV Nord (Germany), Parker Hannifin (US), TUV Austria (Austria), General Electric (GE, US), Acoustic Emission Consulting (AEC, US), Vallen Systeme (Germany), KRN Services (US), and Score Atlanta (US).
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Bottled Water Testing Equipment Market by Technology (Traditional, and Rapid), Component (Instruments, Consumables & Reagents, and Reference Material), Test Type (Microbiological, Chemical, Physical, Radiological), and Region - Global Forecast to 2021
The bottled water testing equipment market, in terms of value, is projected to reach USD 6.46 Billion by 2021, at a CAGR of 5.3% from 2016. Rapid increase in consumption of bottled water, rise in disposable income, awareness about the effects of health due to contaminated water, increase in regulations regarding bottled water quality, and technological developments in the water testing industry are some of the factors driving this market.
- Published: September 2016
- Price: $ 4950
- TOC Available:
-
Urinalysis Market by Product (Consumables (Pregnancy & Fertility Kits, Dipsticks, Disposable, Reagents), Instruments (Automated, Semi-automated, PoC Analyzers)), Test Type (Biochemical, Sediment), Application (UTI, Diabetes) - Global Forecast to 2029
The global urinalysis market, valued at US$4.0 billion in 2023, stood at US$4.3 billion in 2024 and is projected to advance at a resilient CAGR of 9.6% from 2024 to 2029, culminating in a forecasted valuation of US$6.8 billion by the end of the period. Growth in this market is mainly driven by factors such as the increasing burden of urinary tract infections (UTIs), diabetes, and kidney & liver diseases and the increasing adoption of PoC tests.
- Published: February 2025
- Price: $ 4950
- TOC Available:
-
Blood Culture Tests Market by Method (Conventional, Automated), Product (Consumables, Instruments), Technology (Culture, Molecular, Proteomics), Application (Bacteremia, Fungemia), End User (Hospitals, Reference Labs) & Region- Global Forecast to 2028
The global blood culture tests market, valued at US$4.5 billion in 2021, stood at US$5.2 billion in 2023 and is projected to advance at a resilient CAGR of 8.0% from 2023 to 2028, culminating in a forecasted valuation of US$7.6 billion by the end of the period. Growth in this market is majorly driven by the factors such as the growing incidence of sepsis cases and high cost treatment, rising geriatric population, high incidence of bloodstream infections, growing demand for rapid diagnostic techniques and high prevalence of infectious diseases.
- Published: August 2023
- Price: $ 4950
- TOC Available:
-
Microbiome Diagnostics Market by Product (Kits & Reagents, Instruments), Technology (16s rRNA Sequencing, Shot Gun Metagenomics, Metatranscriptomics), Sample (Fecal, Saliva, Skin), Application (GI, Metabolic Disorders) - Global Forecast to 2028
The global microbiome diagnostics market, valued at US$126 million in 2022, stood at US$146 million in 2023 and is projected to advance at a resilient CAGR of 15.5% from 2023 to 2028, culminating in a forecasted valuation of US$300 million by the end of the period. Market growth is driven by the rising incidence of chronic diseases, collaborative efforts between microbiome industry and academic institutes, and growing demand of personalized medicine.
- Published: February 2024
- Price: $ 4950
- TOC Available:
-
Neurological Biomarkers Market by Offering (Consumables, Instruments), Type (Proteomic, Genomic), Application (Alzheimer’s, Parkinson’s), End user (Pharma Companies, Clinical Labs) - Forecast to 2030
The neurological biomarkers market, valued at USD 5.16 billion in 2024, stood at USD 5.53 billion in 2025 and is projected to advance at a resilient CAGR of 10.7% from 2025 to 2030, culminating in a forecasted valuation of USD 9.19 billion by the end of the period.
- Published: April 2026
- Price: $ 4950
- TOC Available:
-
Cell Analysis Market by Product & Service (Consumables, Instruments), Technique (Flow Cytometry, PCR, Microscopy), Process (Counting, Viability, Proliferation, Interaction, Single-cell Analysis), End User (Pharma, Biotech) - Global Forecast to 2028
The global cell analysis market, valued at US$18.6 billion in 2022, stood at US$20.2 billion in 2023 and is projected to advance at a resilient CAGR of 10.9% from 2023 to 2028, culminating in a forecasted valuation of US$33.9 billion by the end of the period. Increase in the preference for cell-bsaed assays along with strong funding for cell-based research is expected to drive the market growth.
- Published: July 2023
- Price: $ 4950
- TOC Available:
-
Cardiac Surgery Instruments Market by Product (Clamps, Forceps, Scalpel, Scissors, Needle Holder), Application (Coronary Artery Bypass Graft, Heart Valve Surgery, Pediatric Surgery, Heart Transplant), & End User (Hospital, ASC) - Global Forecast to 2022
The cardiac surgery instruments market is expected to reach USD 1.63 Billion by 2022 from USD 1.16 Billion in 2017, at a CAGR of 7.1%. The market is mainly driven by factors such as high incidence of cardiac diseases, growing prevalence of cardiac conditions and the subsequent increase in the number of surgical procedures, rising geriatric population, and growing investments, funds, and grants by government bodies worldwide.
- Published: May 2017
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
